These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30485698)

  • 1. Extended-release quetiapine overdose is associated with delayed onset of toxicity compared to immediate-release quetiapine overdose.
    Taylor L; Graudins A
    Emerg Med Australas; 2019 Aug; 31(4):562-568. PubMed ID: 30485698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: a randomised, double-blind, crossover study (eXtRa).
    Riedel M; Schmitz M; Østergaard PK; Ferrannini L; Franco MA; Alfano V; Vansvik ED
    Schizophr Res; 2015 Mar; 162(1-3):162-8. PubMed ID: 25592805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine.
    Capuano A; Ruggiero S; Vestini F; Ianniello B; Rafaniello C; Rossi F; Mucci A
    Drug Chem Toxicol; 2011 Oct; 34(4):475-7. PubMed ID: 21770717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine poisoning: a case series.
    Balit CR; Isbister GK; Hackett LP; Whyte IM
    Ann Emerg Med; 2003 Dec; 42(6):751-8. PubMed ID: 14634598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult clonidine overdose: prolonged bradycardia and central nervous system depression, but not severe toxicity.
    Isbister GK; Heppell SP; Page CB; Ryan NM
    Clin Toxicol (Phila); 2017 Mar; 55(3):187-192. PubMed ID: 28107093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME).
    Karamustafalıoğlu O; Reif A; Atmaca M; Gonzalez D; Moreno-Manzanaro M; Gonzalez MA; Medina E; Bellomo A
    BMC Psychiatry; 2014 Aug; 14():246. PubMed ID: 25174996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
    Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
    Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects.
    Nord M; Nyberg S; Brogren J; Jucaite A; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1357-66. PubMed ID: 21477416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark.
    Emborg C; Hallerbäck T; Jörgensen L; Carlborg A
    Hum Psychopharmacol; 2012 Sep; 27(5):492-8. PubMed ID: 22996616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric pharmacobezoars in quetiapine extended-release overdose: a case series.
    Rauber-Lüthy C; Hofer KE; Bodmer M; Kullak-Ublick GA; Kupferschmidt H; Ceschi A
    Clin Toxicol (Phila); 2013 Dec; 51(10):937-40. PubMed ID: 24199644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents.
    Johnson TN; Zhou D; Bui KH
    Biopharm Drug Dispos; 2014 Sep; 35(6):341-52. PubMed ID: 24797229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.
    Isbister GK; Polanski R; Cooper JM; Keegan M; Isoardi KZ
    Clin Toxicol (Phila); 2022 Sep; 60(9):1019-1023. PubMed ID: 35658766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.
    Bui K; Earley W; Nyberg S
    Curr Med Res Opin; 2013 Jul; 29(7):813-25. PubMed ID: 23574265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpromazine overdose: a case series.
    Berling I; Isbister GK
    Clin Toxicol (Phila); 2024 Jun; 62(6):372-377. PubMed ID: 38889430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression.
    Rajagopalan K; Meyer K; O'Day K; Denno M; Loebel A
    J Med Econ; 2015; 18(10):821-7. PubMed ID: 25985265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.
    Locklear JC; Wahlqvist P; Gustafsson U; Udd M; Fajutrao L; Eriksson H
    J Comp Eff Res; 2014 Jul; 3(4):335-44. PubMed ID: 25275231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kahn RS; Schulz SC; Palazov VD; Reyes EB; Brecher M; Svensson O; Andersson HM; Meulien D;
    J Clin Psychiatry; 2007 Jun; 68(6):832-42. PubMed ID: 17592906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.